Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)
102.77
-0.35
(-0.33%)
Streaming Delayed Price
Updated: 1:42 PM EDT, Aug 10, 2026
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
1 Profitable Stock to Research Further and 2 We Ignore
August 07, 2026
Halozyme Therapeutics Q2 Earnings Call Highlights ↗
August 06, 2026
What To Expect From Halozyme Therapeutics’s (HALO) Q2 Earnings
August 04, 2026
3 Growth Stocks Set to Flourish
August 03, 2026
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore
July 24, 2026
1 Value Stock Worth Investigating and 2 Facing Headwinds
July 15, 2026
2 Reasons to Like HALO and 1 to Stay Skeptical
July 10, 2026
Halozyme (HALO) Q1 2026 Earnings Transcript ↗
May 11, 2026
Halozyme Therapeutics Q1 Earnings Call Highlights ↗
May 11, 2026
Frequently Asked QuestionsIs Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 102.77
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 08/10/26 01:42 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 14.63B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 15B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||
